Skip to main content
. Author manuscript; available in PMC: 2023 Jul 28.
Published in final edited form as: Lancet Microbe. 2022 Jul 27;3(9):e663–e671. doi: 10.1016/S2666-5247(22)00126-4

Figure 4. Rabies glycoprotein-binding antibody responses.

Figure 4

Total glycoprotein-binding IgG responses at each measured timepoint are shown for group 1 (low dose, A), group 2 (middle dose, B), and group 3 (high dose, C). Arrowheads indicate administration of Rabipur (an inactivated rabies vaccine), with samples having been collected before Rabipur administration on applicable days. Each datapoint represents an individual volunteer, with lines connecting datapoints from an individual. Endpoint titres of glycoprotein-binding immunoglobulin isotypes and subclasses at day 28 after administration of ChAdOx2 RabG are shown (D). Each datapoint represents an individual volunteer.